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Abstract 
The study of speciation, as a concept, existed prior to the elucidation of natural selection 
as the mechanism of evolution. However, speciation became a topic of scientific discourse 
starting primarily after the foundation of the modern synthesis. These disciplines operated 
independently; however, leading to the development of multiple theories of speciation. Some of 
the first efforts to consolidate speciation theory originated with the Biological Species Concept 
and the Modern Thesis, collectively introducing major factors of speciation (i.e. habitat, 
genealogy, evolutionary pressure, etc.) (1–3) To clearly define a species, a concise, reusable 
framework is urgently needed in the life sciences; specifically, translational and comparative 
medicine. Each of these fields depends on identifying suitable species to 1) develop a new 
treatment based on laboratory animal studies or 2) to take an existing treatment in humans and 
use it in animals. This is a major concern for pharmaceutical development research. The 
challenge of identifying a suitable species is complex due to a lack of a framework that allows 
for the comparison of species on the gene-gene level. Due to this complexity, gene-gene 
comparison is ignored which can lead to failure in a drug development trial. Subsequently, the 
cost to the development organization in both time and resources, and to society for lack of new 
and effective treatments, maybe great. With the proposed clearly defined, reusable framework, 
researchers would be able to find orthologues disease genes in animals ensuring that those genes 
are operating within the same cellular milieu and comparable physiology. For this reason, we 
have implemented a tool that calculates the evolutionary stability of the gene represented by the 
ratio 
𝐾𝑎
𝐾𝑠
. This ratio can be used to find conserved genes across multiple species and assist in the 
determination of whether that gene is a good candidate for drug targeting and in which species 
the gene exists. In order to meet the needs of researchers in the field; we began integrating 
  
GenBank, KEGG, and Refseq, with this tool, to allow those in the field to easily search across 
species. 
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Chapter 1 - Literature Review 
 Pre-Darwinian Species Concept 
Herbalists were among the first people to adopt a rudimentary classification system for 
living organisms dating back 5000 years to Mesopotamia. (4,5). Their classification system was 
exclusively for plants; specifically, those that could be used medicinally. Aristotle later 
postulated that there were “fixed forms” that existed in the surrounding universe; on which the 
universe has some effect; however, he did not know how to predict that effect or when it might 
be observed.(6,7) Epicurus, who studied under Plato, suggested theories about atoms, their 
properties, and their ability to affect other atoms; as well as go through physical changes over 
time.(8–10) Later his concepts of atoms were used to describe atoms as beneficial or harmful to 
other atoms, and humans.(9,10)  Thereafter, humans have contemplated their order among other 
organisms and in doing so, stumbled upon the precarious task of grouping organisms into classes 
to be studied, now described as species. “Speciation, the evolution of reproductive isolation 
among populations, is continuous, complex, and involves multiple, interacting barriers”(11) and 
“any discussion of the genetics of speciation must begin with the observation that species are real 
entities in nature, not subjective human divisions of what is really a continuum among 
organisms.”(12) Intuitively, over time, speciation researchers began by looking at the physical 
features of an organism and the field of phenetics was born; formally known as a Pre-Darwinian 
classification system, phenetics is based primarily on the phenotypic attributes of an 
organism.(4) Those working in the field operate under the Aristotelian assumption that all 
organisms are “fixed”, in other words, they do not change over time. In doing this, two types of 
classification systems were employed: priori and posteriori, later described as artificial and 
natural, respectively. (4,13) Theophrastus, a student of Aristotle, was the first to classify plants 
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by habitat and whether they were cultivated or wild. For this reason, he is commonly referred to 
as the Father of Botany. (4,13) This is one of the earliest observed systems of taxonomy, which 
created operational taxonomic units (OTUs) using previously given criteria characterizing this 
system as priori classification. Linnaeus made this method famous in 1735 as is displayed in his 
Regnum Animale which established the binomial nomenclature system which is still used today 
and is fundamental to the field of taxonomy.(4,13,14)  Antoine Laurent de Jussieu’s Genera 
Plantarum introduced his “sexual system” in 1789, grouping plants according to the number 
stamens and pistils in the flower while employing Linnaeus’ binomial nomenclature.(4,15,16) 
Conversely, he used many different characteristics and created OTUs as each characteristic was 
studied, naturally, characterized as posteriori classification.(4,12,13) Augustin Pyramus de 
Candolle employed this in his Prodromus Systematis Naturalis Regni Vegetabili, a 17-volume 
also known as Prodr. (DC.) pertaining primarily to dicotyledons. It has been used to develop the 
field of plant taxonomy through the 1900s.(4,17,18) Charles Darwin, prompted by Alfred 
Wallace, brought the discussion of evolution to the main stage. Its established implementation 
into speciation, however, did not come until later in the 20th century(7). Simpson standardized 
the nomenclature used when studying taxonomy by establishing fundamental terms (e.g. 
Classification, Identification, Systematics, Taxonomy) which created a scalable framework for 
the study of speciation, outlined in his text Principles of Taxonomy.(19,20)  
 Post-Darwinian Species Concepts  
 Through the 20th century, there was an explosion in the volume of OTUs that were 
characterized. This created a large amount of information to be studied. It became cumbersome 
and expensive to continue studying OTUs in a nonsystematic manner, which lead Sneath and 
Sokal to the creation of the field of numerical taxonomy, one of the first manifestations of 
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Simpon’s Systematics (19,20). Similarly, OTUs were used to determine relationships between 
traits; however, it allowed for the use of a significantly larger data set.(4,21–23) Sneath and 
Sokal built an empirical methodology that allowed overall similarity to be distinguished from the 
phylogenetic relationship by calling it a phenetic relationship, indicating that it be judged by the 
phenotype of the organism and not its phylogeny.(20) Doing so, created two fields of study, 
those who subscribed to the idea of evolution’s effect on speciation and those that chose to stay 
firmly within the bounds of phenetics. While numerical phenetics is well accepted in the 
botanical systems, those who studied cladistics and evolutionary classification vigorously 
objected to the use of numerical phenetics. (24) Those objecting raise the issue of homoplasy  
(e.g. both octopi and humans have complex compound eyes; but in octopi, they are of a separate 
derivation than humans).(25) For this reason, those in the field began searching for a more 
effective and accurate way of classifying organisms, leading to the creation of the Biological 
Species Concept and The Modern Synthesis. 
 Biological Species Concept (BSC) 
“Species are groups of actually or potentially interbreeding natural populations that are 
reproductively isolated from other such groups”(26) as defined in the Biological Species Concept 
introduced by Dobzhanksy in 1937, Muller and Mayr in 1942.(26,27) This concept characterizes 
two major barriers that allow for speciation to occur: prezygotic and postzygotic. (26)  
Prezygotic barriers are centered primarily on the sexual behavior of an organism. Before 
an organism can begin the process of genetic inheritance, that organism must be in the same 
geographic vicinity as a potential partner. This simple obstacle has developed into the fields of 
ecological and geographic speciation introduced by Van Valen(3) and characterized by 
Barraclough(28), respectively(29). Only thereafter can a pair of organism’s ethology come into 
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play, such as a male’s plumage or courtship behavior, which can pleiotropically produce sexual 
isolation and conceivably selection.(12,29) Sexual selection’s effects on speciation were first 
introduced by Haskins and Haskins in 1949 and further studied by Coyne and Orr in 
1998.(12,26,28,30). Logically, after two organisms have interacted and successfully courted each 
other, the next obstacle would be the physical mechanics involved in the act of copulation, such 
as female’s control of sperm usage, or male-male sperm competition within multiple inseminated 
females.(12,29) However, the latter of the three examples could be effected by gametic 
compatibility as well. (26) Nearly all prezygotic isolation mechanisms occur sympatrically, 
potentially allowing for the formation of several species from a single population. (31–36) 
However, focusing on the reproductive compatibilities and patterns of interbreeding can cause a 
misrepresentation of the significance of hybridization among differentiated taxa”(37), which 
drives the conversation further towards the next of the two barriers responsible for speciation 
within this concept. (38) 
 Postzygotic barriers indicatively occur after fertilization has taken place and manifests as 
either hybrid inviability or sterility, effectively an unfit organism.(12,26,39) “The genetics of 
hybrid sterility and inviability quickly grow complex as species diverge”(12,40); however, it 
complicates where the line is to be drawn between one species to another. The Dobzhansky-
Muller model sought to resolve some of this complexity through the following central 
assumption; “Alleles cause no sterility or inviability on their normal “pure species” genetic 
background”.(40) As well, it posits that postzygotic isolation arises in allopatry as a side-effect 
of ordinary evolutionary divergence(39) and naturally implies that the genetics of speciation will 
grow very complex very fast. (39)  Significantly this shows that the evolution of hybrid sterility 
or inviability need not involve any intermediate, maladaptive step, later characterized as a 
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missense mutation. (40) Yet, “doubling of genetic divergence can cause at least a fourfold 
increase in the expected number of incompatibilities contributing to hybrid sterility, therefore 
genetic analysis of long-diverged-species might grossly overestimate the number of substitutions 
needed to obtain speciation”.(39) The difficulty lies in how to methodically characterize species 
in growing gene pools where the genetic variation within them is consistently rising. The 
biological species concept is widely used because it describes the present and possible 
evolutionary future, as well as the concepts of limited gene exchange. However it has limitations 
as it does not consider asexual species, evolutionary history, and it only focuses on a small 
window of time, typically that which can be observed in living organisms. (33,34) For those 
reasons, those in the field have looked for a better species concept that does not have these 
issues.  
 Phylogenetic Species Concept (PSC) 
The PSC began when Huxley introduced The Modern Synthesis in 1887; joining 
Mendelian genetics with Darwinian theories on evolution(1). The BSC and PSC did not exist 
dichotomously; Dobzhansky, an author of the BSC, stated, “genetics has so profound a bearing 
on the problem of the mechanisms of evolution that any evolution theory which disregards the 
established genetic principles is faulty at its source”.(2) However, PSC’s popularity did not grow 
until major advancements in the field of systematics had taken place, allowing for the further 
development of the study of evolutionary biology. (38) Early studies focused on the development 
and analysis of cladistics first introduced by Willi Hennig in 1950 and introduced a phylogenetic 
species as “an  irreducible basal cluster of organisms that is diagnosably distinct from other such 
clusters, and is the smallest monophyletic group of common ancestry”.(13,25,37,41)  Cladistics 
manifests as cladograms or phylogenetics trees where three different relationships can be 
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displayed: Monophyletic, Paraphyletic, Polyphyletic. (13) Throughout the late 1900s, cladistics 
was applied and intertwined with the Biological, Ecological, Genealogical, and Evolutionary 
species concepts, amassing a swath of information to be studied. Leading to Wheeler and 
Nixon’s statement: 
“The militant view that systematists need to embrace is that the responsibility for 
species concepts lies solely with systematists. If we continue to bow to the study 
of process over pattern, then our endeavors to elucidate pattern become 
irrelevant.”(42) 
 Introduction Modern Systematics 
The National Institute of Health (NIH) took Wheeler and Nixon’s statement to 
heart and founded both the National Center for Biotechnology Information (NCBI), 
which worked to create and maintain biomedical databases(43), and the Human Genome 
Project (HGP), “an international, collaborative research program whose goal was the 
complete mapping and understanding of all the genes of human beings”.(44) The 1990s 
was a time for advancement in sequencing of genomes from various species and 
subsequently which created the need for cataloging of all this new, highly granular, 
information. Genbank(45) was created primarily to accommodate nucleic acid and amino 
acid records from data sources around the world namely, EMBL-Bank, (DDBJ) and, 
NCBI; who make up the International Nucleopeptide Sequence Database (INSDC). (45) 
As the name implies, GenBank is a repository of genetic information, but it does provide 
a clean, curated dataset for researchers to use, for this reason, Refseq was founded. (45) 
 The RefSeq project leverages data submitted to the (INSDC) against a combination of 
computation, manual curation, and collaboration to produce a standard set of stable,  
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non-redundant reference sequences. The database currently represents sequences from 
more than 55,000 organisms, ranging from a single record to complete genomes. (46)  
The GENE and the GENOME project are products of the INSDC and hosted by 
the NCBI. GENE creates analytical support for this incoming data; while the former 
worked to curate accommodate the contextual needs of each genetic records (i.e. map, 
sequence, expression, structure, function, citation, and homology data).(47) GENOME 
developed BLAST, a very powerful alignment tool; As well it is the home of the Human 
Genome Project as well as many other sequencing/annotations projects.(44,48) The 
United States was not the only country leading this effort; Japan’s KEGG created an 
integrated database resource consisting of fifteen manually curated databases and a 
computationally generated database in four categories which also contains GENOME and 
GENES, this integration made possible through the DBBJ membership in INSDC.(49) 
KEGG created the KO database, a collection of genes and proteins, which are curated 
into intricate pathway maps, that allow the user to visualize their protein of interest 
within the various pathways in which it is involved and their relationship to the proteins 
lying upstream and downstream.(49) UniProtKB a member of EMBL-EBI, concerned 
primarily with the curation of the human genome and related data created partnerships 
with Swiss’s SERI and SIB, together, they were the first to publish the complete human 
proteome in 2008. (50–53) There are numerous other organizations that have made 
advancements in the field of data collection and analysis, however, for the purposes of 
this study, we will limit our review to those mentioned above and utilized in our work.  
8 
 Applying Bioinformatics to the species problem 
In the case of translational medicine and drug discovery, it is imperative to have a 
thorough understanding of the genetics at work within the species of interest in order to 
understand its pharmacodynamics and how those dynamics will translate to humans. However, 
due to the issues within the aforementioned methodologies for species classification, it becomes 
difficult to predict the exact effect a treatment will have in a species of interest and if that 
treatment will subsequently translate to humans. For this reason, there is a need for a framework 
for finding homologous pairs that: perform the same function, are evolutionarily stable and are in 
a similar physiological location within the taxonomic class. Here we present such a framework, 
which leverages relevant fundamental genetic data from the INSDC, DDBJ, and EMBL 
databases in a format that can be connected to the human and animal health information, in order 
to provide both contextual and computational base for which translational research to be 
conducted. 
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Chapter 2 - Methods and Results 
 Evolutionary Rate Framework 
The following methods are adapted from the Wisconsin package, a software developed 
originally at the University of Wisconsin-Madison, and sold through several corporate entities 
since. Their method was adapted from Louis, who adapted the computational methods from Li et 
al, who implemented Kimura’s Two Parameter method. (54–56)  
The script begins by searching GenBank’s directories for all nucleic and amino acid pairs 
(325,952 pairs) in mammals (a.k.a gbmam). It then performs reverse translation, using the 
provided amino acid sequence, in order to verify that the provided nucleic acid (NA) sequence 
codes for the provided amino acid (AA) sequence; if extra NA sequence is provided on either 
end, the excess is removed, leaving only the coding sequence (CDS). Due to the large number of 
incomplete or partial records in GenBank, this leaves approximately 93,000 pairs. Each of the 
93,000 NA sequences is aligned to one another using a global alignment algorithm (Needleman–
Wunsch) provided by BioPython(57); creating approximately 8,605,000,000 alignments.  
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Figure 1. Workflow for calculation of Codon Degeneracy and Tranversional/Transitional 
Frequency 
Depicted in Figure 1, two sequences are aligned and broken up into codon pairs. Each 
codon in a set is classified into one of three codon degencery categories (𝐿0, 𝐿2,𝐿4) using the key 
in Figure 2.  
 
Figure 2. Key for Codon Degeneracy  
The average codon degeneracy for the alignment is obtained by counting the number of 
non-degenerate (𝐿0), twofold degenerate (𝐿2), and fourfold degenerate (𝐿4) amino acids and 
dividing the sum of each by two as depicted in Figure 1. Each codon within a set is compared to 
the other and the frequency of transversion (𝑉𝑖) which is changed from  
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(A<->C, A<->U, U<->G, C<->G) and transition (𝑆𝑖) (A<->G, C<->U) are collected and sorted 
by their codon degeneracy designation (𝑆0, 𝑆2, 𝑆4, 𝑉0, 𝑉2, 𝑉4). 
𝑃0 =
𝑆0
𝐿0
 𝑃2 =
𝑆2
𝐿2
  𝑃4 =
𝑆4
𝐿4
 
𝑄0 =
𝑉0
𝐿0
 𝑄2 =
𝑉2
𝐿2
  𝑄4 =
𝑉4
𝐿4
 
Figure 3. Transitional and Trasnsversional distance equations 
Transitional (𝑃𝑖) and Tranversional (𝑄𝑖) distances are calculated by taking the ratio of the 
frequency of each transitional or transversion total and each codon degeneracy total respective of 
its codon degeneracy designation shown in Equations above.  
 
 
𝑎0 = 1 − (2 ∗ (𝑃0 − 𝑄0)   𝑏0 = 1 − (2 ∗ (𝑄0)  
𝑎2 = 1 − (2 ∗ (𝑃2 − 𝑄2)   𝑏2 = 1 − (2 ∗ (𝑄2)  
𝑎4 = 1 − (2 ∗ (𝑃4 − 𝑄4)   𝑏4 = 1 − (2 ∗ (𝑄4)  
𝛼0 = (−0.5 ∗ ln(𝑎0)) + (0.25 ∗ ln(𝑏0))   𝛽0 = −0.5 ∗ ln(𝑏0)  
𝛼2 = (−0.5 ∗ ln(𝑎2)) + (0.25 ∗ ln(𝑏2))   𝛽2 = −0.5 ∗ ln(𝑏2)  
𝛼4 = (−0.5 ∗ ln(𝑎4)) + (0.25 ∗ ln(𝑏4))  𝛽4 = −0.5 ∗ ln(𝑏4)  
 
The Transitional (𝐿𝑖) and tranversional (𝑉𝑖) distances are used to calculate 
(𝑎0,, 𝑎2,, 𝑎4,, 𝑏0,, 𝑏2,, 𝑏4,), which are then used in Kimura’s two-parameter test 
(𝛼0,, 𝛼2,, 𝛼4,, 𝛽0,, 𝛽2,, 𝛽4,) which estimates the true number of transitional and tranversional 
substitutions for each degencery designation per site, as depicted in Figure 4. Ultimately the ratio 
of non-synonymous change (𝐾𝑎,) and synonymous change (𝐾𝑠,) are calculated using the codon 
Figure 4 Kimura’s Two Parameter Test - Left: Depiction of Transversion and Transition and 
its application to Kimura’s Two Parameter test. Right: Depiction of calculations used in 
Kimura’s Two Parameter Test. 
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degencery frequency values (𝐿0, 𝐿2,𝐿4) and the values generated from Kimura’s two-parameter 
test (𝛼0,, 𝛼2,, 𝛼4,, 𝛽0,, 𝛽2,, 𝛽4,), depicted in Figure 5.  
𝐾𝑠 =
𝛽4, + (𝐿2, ∗ 𝛼2,) + (𝐿4 ∗ 𝛼4,)
𝐿2, + 𝐿4,
 𝐾𝑎 =
𝛼0 + (𝐿0 ∗ 𝛽0) + (𝐿2 ∗ 𝛽2,)
𝐿0, + 𝐿2
 
𝐾𝑎
𝐾𝑠
 
Figure 5. Top: 𝑲𝒂, 𝑲𝒔 calculation.  Bottom: 𝑲𝒂, 𝑲𝒔 Ratio 
However, not all sequence pairs will reach this stage, if (𝑎𝑖, 𝑜𝑟 𝑏𝑖,) are not greater than 
zero, then the respective 𝛼0 or 𝛽0 will be undefined and subsequently, the calculation will end at 
this stage. Similarly, if  the sum of  (𝐿2 and 𝐿4) or (𝐿2 and 𝐿2) equal zero then 𝐾𝑎 or 𝐾𝑠 will be 
undefined respectively, the same logic applies if 𝐾𝑠is equal to zero. For these reasons, the result 
of the script will have less than 8,605,000,000 results. 
The results generated by the script are classified into three categories based upon the 
calculated 
𝐾𝑎
𝐾𝑠
 value. Gene pairs that have a 
𝐾𝑎
𝐾𝑠
  less than 1 are considered to be under negative or 
purifying selection, those genes with 
𝐾𝑎
𝐾𝑠
 greater than 1 are under positive or Darwinian selection 
and those with a 
𝐾𝑎
𝐾𝑠
 equal to 1 are under neutral selection. The 
𝐾𝑎
𝐾𝑠
 values were calculated 
regardless of the species of origin, this was done in order to find mislabeled genes within 
GenBank gbmam dataset. For this reason, it was imperative to align gene pairs with those in 
Refseq in order to determine if those genes are comparable, meaning they are the same or similar 
genes.   
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 Ontological Framework  
Sequence pairs that have 
𝐾𝑎
𝐾𝑠
 values are aligned with sequences from Refseq, again, using 
the Needelman-Wunsch alignment method. This creates a list of the species for which each gene 
exists. This list of species can be used to create a gene tree, which will depict if a gene exists in 
multiple species. If a gene is shared across multiple species, their respective amino acid 
sequences can be used to search UniprotKB, which serves as a connection to the KEGG database 
by providing the KEGG ID. If a KEGG ID exists, that ID is then used to search the KEGG 
database to determine if the gene pairs are found to be in the same cellular milieu and pathway. 
The script then creates a record containing: Unique comparison ID (Internal Use), Genbank ID, 
RefSeq ID, Uniprot ID, KEGG ID, and the sequences.  
 Development in an Open Source Environment: 
The aforementioned framework is implemented on a server that runs Ubuntu 16.04 LTS 
server operating system. Python 3.0 was chosen due to its vast community support and its ability 
to multi-thread and be run in parallel, which improves the speed at which tasks are completed, 
and is well supported in Ubuntu Linux environment. The database system chosen was MySQL 
for its ability to quickly store and retrieve structured information and it is well supported in the 
Ubuntu Linux system.   
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Chapter 3 - Discussion  
Translational Medicine  
The ontological framework’s objective is to provide a curated database of mammalian 
genes with information pertaining to their evolutionary stability and conservation across other 
mammals. A gene’s evolutionary stability is a strong indicator of its conservation either within or 
across species. If a gene pair is not under selection and is conserved; it can be inferred that the 
gene pair could be a good target for pharmaceutical development. However, highly conserved 
genes may be highly expressed in an organism, and for that reason, designing a highly specific 
pharmaceutical could be challenging, as the gene may be doing various functions in various 
tissues, which would result in various pharmaceutical effects that in some cases would be 
adverse to the species in question. For those in the field of translational medicine, challenges 
such as these are an everyday occurrence. Many pharmaceuticals have failed due to these 
challenges in the understanding of the translational aspect of a pharmaceutical’s development. 
This failure commonly manifests, when the drug is taken from a “successful” animal trial and 
implemented into human testing. Where, it may either “fail early” meaning that at Phase 1 the 
drug was causing serious side effects, or it will fail in late Phase 2/early Phase 3 due to lack of 
efficacy. This failure occurs because the intended receptor the pharmaceutical is targeting in the 
human may not be in the same cellular milieu or possibly not in the same pathway, as the tested 
animal model. This gap in knowledge has affectionately been named the “Valley of Death”. 
However, pharmaceutical companies work hard to ensure that their pharmaceuticals do not fail; 
an early Phase 1 failure can cost upwards of 100 million dollars and late Phase 2/ early phase 3 
can be upwards of 200-300 million dollars. This immense cost is a risk to any company in the 
field and for that reason, pharmaceutical companies have shifted away from doing the pre-phase 
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2 research and development, in favor of buying smaller biotech companies who have already 
successfully completed those steps. The immense cost to pharmaceutical companies has created 
an incentive in the field of translational research, in that, funding is available for those 
innovating the field as the pharmaceutical industry attempts to mitigate these costly failures.  
Translational research should go both ways; when a drug is developed for a human, an 
animal model is used, therefore, at the end of the drug development pipeline, two drugs should 
exist: One for the human and one for the animal, used as the animal model. The 
pharmacokinetics, as well as the efficacy and safety data collected during the animal trial, can 
then be used to design drugs for other mammals with similar cellular targets and systemic 
physiology. Designing drugs with multiple species in mind, can mitigate the risk of financial 
investment as it is diversified across multiple animals and subsequently multiple revenue 
streams.  
 Integration of human and animal health data 
There has been a recent rise in intra/inter-health record analysis due to advancements in 
electronic medical record (EMR) software(s) and their ability to provide diagnostic assistance 
tools to physicians. This advancement has allowed hospital systems, as a whole, to gain insight 
into their patient population; allowing them to optimize patient care, reduce short-term re-
admittance, and allocate resources proactively to growing departments. The integration of health 
records to this ontological framework could provide further insight for future pharmaceutical 
development and reinforce that all side effects are population dependent, and the first step to 
their mitigation is identification and classification of their cause. The collection for side effects 
stratified based upon hospital or region could provide better insight into specific pharmaceuticals 
within those populations and subsequently, expand our understanding of the genetic diversity 
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within and across human populations. However, the use of health records to assist phase 4 drug 
monitoring has yet to be implemented on a large scale partly because the process of anonymizing 
human health records and sharing that data with other organizations is complex. Further, the 
present method for tracking a drug's performance, in both humans and animals, is by looking at 
the FDA adverse drug events (ADE) database(58). There you will find millions of ADEs, 
however, there is not a standard method for discerning if a reported symptom is caused by the 
reported drug or if it is a symptom that patient is suffering independent of the reported treatment 
or other coexisting conditions such as concomitant disease, diet or multiple drugs being 
administered. (59)  
Human healthcare institutions are a large source of human health data, and a vast amount 
of time and resources were implemented to obtain and curate that data in a meaningful format. 
However, these institutions are not owners of this information; as it is the property of the patient. 
For this reason, there has been a push to enroll patients into data-sharing agreements, which 
allow health care institutions to share human health data through organizations like iShare 
medical,(60) which allows patients to share their own medical records. Research programs like 
1Data(61) at Kansas State University(62) could then combine that human data with animal 
health information along with ADE and genetics information to build out a more robust 
translational research framework.(59,63)  
There is an additional layer of translation that can occur within just animal species. This 
includes developing drugs for multiple breeds for example of dogs, cats or cattle. In addition, 
disease manifestations may be very different between different animal species and humans, or 
even within breeds of a species. Classic examples, many having a pharmacogenomic basis, 
include species and breed differences in nutritional requirements due to very different 
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gastrointestinal physiology, drug-metabolizing enzymes (cytochrome p450 system 
polymorphisms) and drug transporter systems (e.g. P-glycoprotein regulated by the MDR1 or 
ABCB1 gene). The later results in a greatly increased sensitivity of collie dogs to ivermectin 
exposure compared to most other breeds. In addition to these pharmacogenomic variables, drug 
development across species is also dependent on different body sizes (e.g. a mouse to a horse) 
which results in the need for allometric scaling or using detailed blood-flow sensitive 
pharmacokinetic models. Great progress has been made in these areas, however, successful 
translation is a multifactorial and complex situation that requires parallel studies in comparative 
genomics as well as pharmacokinetic and cellular response systems. (64)  
 Evolutionary analysis 
It is understood that 𝐾𝑎, 𝐾𝑠, and 
𝐾𝑎
𝐾𝑠
 constitute the amino acid substitution rate, mutation 
rate, and selective pressure, respectively. However, using 
𝐾𝑎
𝐾𝑠
 or 𝐾𝑠 essentially ignores codon bias; 
therefore, while we consider 𝐾𝑠 to be the mutation rate it's better characterized as the fixation 
rate for synonymous mutations. (65)  It also understood that sequences that show high codon bias 
is associated with lower 𝐾𝑠 values. (66)  It then comes as no surprise that high 𝐾𝑠 values are 
correlated with high 
𝐾𝑎
𝐾𝑠
 values because genes that are under heavy codon bias constraint are 
likely under even higher nonsynonymous mutation constraint. Although 𝐾𝑎, 𝐾𝑠, and their ratio 
have some translational specificity, it is prudent to consider all three when characterizing the 
influence of their conversation and how that affects two gene’s relationship to one another as 
well as their ability to be targeted for drug development. “Our understanding of intragenomic 
mutation rate variation remains limited and is drawn from a relatively small number of model 
organisms.”(11) For this reason, we sought to implement a framework that would alleviate the 
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need for a researcher to consult multiple data sources in order for them to conduct translational 
genomic analysis; thereby accelerating the field's understanding of intragenomic mutation rates 
by providing an ontology for which they can cross-reference their findings. In order to extend 
this analysis to the creation of phylogenic trees based on genetic similarity, we would then need 
to calculate a 'total species divergence' based on the composite of the total pathway divergences. 
This would allow for clustering analysis to take place while maintaining the integrity of the 
research aim to find good model organisms for drug target pathways. In order to alleviate codon 
bias, and to better serve cluster analytical methods it may be beneficial to implement Grantham 
distance and BLOSUM62 in order to interpret instances where 𝐾𝑎 is equal to 𝐾𝑠 and where 𝐾𝑠 is 
far grater than 𝐾𝑎.    
Absolute mutation rates (i.e. the number of mutations per site and generation) are 
nonuniform across the genome, and the implementation of genome-wide mutation rate variation 
should be taken into consideration in order to interpret the genomic landscape accurately. (67,68) 
 Application to the Species problem  
It is imperative to subscribe to a system of speciation that allows for the accurate and 
consistent investigation of organisms; “Understanding the demographic and evolutionary history 
of population and species pairs is necessary to generate expected patterns of genomic 
differentiation.”(11) Through further development in the understanding of humans and animals 
and as their genetic and evolutionary history become more clear, it may become easier to classify 
species and be able to develop more stringent and clear criteria on what separates one species 
from another.  
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 Further Development of the Framework 
The next two steps in developing this framework for end-users is viability and speed. At 
this time, the developed framework is not readily available to the public. It is a collection of 
command-line tools that do not have a graphical user interface (GUI) nor are the individual tools 
user-friendly. In order to mitigate this, the construction of a web-based front-end would be 
beneficial, as it would provide a venue for end-users to access and use it without having to learn 
Python(69) or any other coding language. However, when applications are web-based, 
precautions must be put into place in order to protect the integrity of the app as well as the 
security of any data stored within it. For that reason, Django (70), web-framework written in 
Python as well, would be a logical choice as it is known for its security and flexibility in 
developing a web-based interface. Django would allow for several levels of user access (i.e. 
Database administrators, end-users) as well as handling user-authentication and management, 
saving time in development and technical support. Django’s (70) framework can be used to 
allow researchers to submit their data, and view it among the 1Data (61) dataset as well as access 
and use analytical tools such as 
𝐾𝑎
𝐾𝑠
 calculation or the ontological framework. (63) As well, the 
Django web framework would allow for the future implementation of other analytical tools.  
Speed is the next challenge, as stated above in the 
𝐾𝑎
𝐾𝑠
 calculation there are over 8 billion 
computations to complete. At present, the server that performs this task can complete up to 20 
calculations per second (20 cores at one calculation per core per second) which would take 
approximately 13 years to complete. In order to mitigate this several steps could be taken: the 
simplest would be upgrading the server from Ubuntu version 16 to Ubuntu version 18, which 
would increase the scripts run time. However, it is likely that the completion time would still be 
measured in years. The next step might be moving all data stored in MySQL to PostgreSQL, 
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which could take months off the completion time, as PostgreSQL indexing algorithm is much 
simpler and more robust. However, the most important step would be, optimization of the python 
scripts and potentially changing the algorithm to allow easier parallelization, to allow it to be 
implemented on Beocat which has more than 1000 cores. This would allow the script to be 
completed in as few as 14 weeks.   
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Chapter 4 - Conclusion 
Researchers in all fields of biology rely on a clear concise definition of species, whether 
it is using the methods defined above or using methods yet to be written; it is paramount for the 
further development of the life sciences that a reproducible and abstractable definition be 
determined and implemented. The phylogenetic species concept provides much of the needed 
framework for speciation determination; however, it lacks a computational component to discern 
between two closely related species, and for this reason, requires further development.   
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